OSI Pharmaceuticals, Inc. (OSIP) Announces Occurrence of a Fundamental Change for Convertible Notes  
6/18/2010 1:35:35 PM

MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (the “Company”) announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the “notes”) are convertible at the option of the holders and will remain convertible at least through July 19, 2010, as provided for in the Indenture (the “Indenture”) governing the notes.